Cubist Pharmaceuticals (CBST) volatility low at 49
Cubist Pharmaceuticals (Nasdaq: CBST) closed at $17.06. CBST's Cubicin is the first antibiotic in a new class of anti-infective called lipopeptides. CBST over all option implied volatility of 49 is below its six month average of 57, according to Track Data, suggesting decreasing price movement. Paul Foster
You May Also Be Interested In
- OmniVision (OVTI) Volatility Up on Move Lower
- Cree (CREE) Volatility Elevated as CFO Slide Continues
- Office Depot (ODP) Volatility Up into Late-Session Move Higher
Create E-mail Alert Related Categories
OptionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

Up)